Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.22M Sell
114,615
-18,878
-14% -$503K 0.89% 16
2025
Q4
$3.32M Sell
133,493
-1,235
-0.9% -$31.1K 0.87% 14
2025
Q3
$3.43M Sell
134,728
-14,691
-10% -$363K 0.88% 15
2025
Q2
$3.62M Buy
149,419
+39,211
+36% +$914K 0.94% 11
2025
Q1
$2.79M Sell
110,208
-18,593
-14% -$487K 0.74% 31
2024
Q4
$3.42M Buy
+128,801
New +$3.49M 0.85% 22
2024
Q2
Sell
-100,597
Closed -$2.79M 215
2024
Q1
$2.79M Buy
+100,597
New +$2.79M 0.58% 41
2023
Q1
Sell
-32,500
Closed -$1.67M 219
2022
Q4
$1.67M Buy
+32,500
New +$1.56M 0.36% 68
2022
Q3
Sell
-117,480
Closed -$6.03M 136
2022
Q2
$6.03M Buy
117,480
+84,204
+253% +$4.29M 1.3% 22
2022
Q1
$1.62M Buy
33,276
+27,650
+491% +$1.43M 0.26% 92
2021
Q4
$319K Sell
5,626
-1,199
-18% -$59.4K 0.05% 152
2021
Q3
$278K Sell
6,825
-80,043
-92% -$3.55M 0.05% 165
2021
Q2
$3.4M Buy
86,868
+80,521
+1,269% +$3.13M 0.52% 43
2021
Q1
$230K Sell
6,347
-235,420
-97% -$8.36M 0.04% 172
2020
Q4
$8.9M Buy
241,767
+49,205
+26% +$1.8M 1.35% 14
2020
Q3
$6.71M Buy
+192,562
New +$6.75M 1.03% 33
2019
Q3
Sell
-67,140
Closed -$2.76M 264
2019
Q2
$2.76M Buy
+67,140
New +$2.67M 0.24% 88
2018
Q4
Sell
-52,178
Closed -$2.18M 200
2018
Q3
$2.18M Sell
52,178
-802,962
-94% -$30.9M 0.12% 134
2018
Q2
$29.4M Buy
+855,140
New +$29.2M 1.56% 19
2014
Q4
Sell
-595,825
Closed -$16.7M 226
2014
Q3
$16.7M Buy
+595,825
New +$16.7M 0.5% 53
2014
Q2
Sell
-200,519
Closed -$6.11M 124
2014
Q1
$6.11M Buy
+200,519
New +$5.98M 0.27% 82

Other funds holding PFE

WBI Investments's PFE Position: Q1 2026 in Review

WBI Investments reduced its Pfizer (PFE) stake by 14% in Q1 2026, selling an estimated $503K and leaving 114,615 shares worth $3.22M. The position accounts for 0.89% of the portfolio, ranked #16.

WBI Investments first reported a position in PFE in Q1 2014 and has held it in 21 quarters since. The position peaked at $29.4M in Q2 2018. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • WBI Investments held 114,615 shares of Pfizer worth $3.22M as of Q1 2026.
  • WBI Investments sold 18,878 Pfizer shares in Q1 2026, an estimated $503K.
  • Pfizer made up 0.89% of WBI Investments's portfolio in Q1 2026, its #16 holding.
  • WBI Investments first reported a position in Pfizer in Q1 2014 and has held it in 21 quarters since.
  • WBI Investments's Pfizer position peaked at $29.4M in Q2 2018.
  • 2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on WBI Investments's 13F filing for Q1 2026, filed 11 May 2026.